ATE401313T1 - Herstellung von risperidon - Google Patents

Herstellung von risperidon

Info

Publication number
ATE401313T1
ATE401313T1 AT07001138T AT07001138T ATE401313T1 AT E401313 T1 ATE401313 T1 AT E401313T1 AT 07001138 T AT07001138 T AT 07001138T AT 07001138 T AT07001138 T AT 07001138T AT E401313 T1 ATE401313 T1 AT E401313T1
Authority
AT
Austria
Prior art keywords
risperidone
production
disclosed
methods
present
Prior art date
Application number
AT07001138T
Other languages
English (en)
Inventor
Barnaba Krochmal
Dov Diller
Ben-Zion Dolitzky
Judith Aronhime
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26919535&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE401313(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE401313T1 publication Critical patent/ATE401313T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07001138T 2000-08-14 2001-08-14 Herstellung von risperidon ATE401313T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22536100P 2000-08-14 2000-08-14
US24326300P 2000-10-25 2000-10-25

Publications (1)

Publication Number Publication Date
ATE401313T1 true ATE401313T1 (de) 2008-08-15

Family

ID=26919535

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07001138T ATE401313T1 (de) 2000-08-14 2001-08-14 Herstellung von risperidon

Country Status (20)

Country Link
US (2) US6750341B2 (de)
EP (2) EP1982980A1 (de)
JP (3) JP3751942B2 (de)
KR (2) KR100818875B1 (de)
AT (1) ATE401313T1 (de)
AU (1) AU2001284880A1 (de)
CA (1) CA2419314C (de)
CZ (1) CZ2003668A3 (de)
DE (1) DE60134899D1 (de)
ES (1) ES2310410T3 (de)
HR (1) HRP20030154B1 (de)
HU (1) HUP0302874A2 (de)
IL (2) IL154417A0 (de)
IS (1) IS6713A (de)
MX (1) MXPA03001337A (de)
NZ (1) NZ524554A (de)
PL (1) PL365608A1 (de)
PT (1) PT1783118E (de)
SK (1) SK2982003A3 (de)
WO (1) WO2002014286A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
AU2003256006A1 (en) * 2002-08-30 2004-03-19 Sunil Sadanand Nadkarni Improved process for preparation of risperidone
KR20040034996A (ko) * 2002-10-18 2004-04-29 한미약품 주식회사 리스페리돈의 개선된 제조방법
EP1560814A1 (de) 2002-11-13 2005-08-10 Synthon B.V. Verfahren zur herstellung von risperidon und zwischenprodukte
US20040180935A1 (en) * 2003-02-28 2004-09-16 Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Inc. Crystalline form Z of rabeprazole sodium and process for preparation thereof
AU2003245028A1 (en) * 2003-04-16 2004-11-04 Hetero Drugs Limited A novel crystalline form of risperidone
ES2803516T3 (es) 2003-10-16 2021-01-27 Symed Labs Ltd Una forma cristalina de linezolid
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
KR101242486B1 (ko) * 2004-01-12 2013-03-13 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 장기 전달을 위한 제형 및 그의 이용 방법
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
ES2294494T3 (es) * 2004-04-19 2008-04-01 Symed Labs Limited Un nuevo procedimiento para la preparacion de linezolid y compuestos relacionados.
HUP0401379A3 (en) 2004-07-08 2006-04-28 Richter Gedeon Vegyeszet Process for the preparation of risperidon
US20080262445A1 (en) * 2004-09-08 2008-10-23 Dermatrends, Inc. Transdermal Delivery of Hydrophobic Bioactive Agents
HUP0402163A2 (en) * 2004-10-25 2006-05-29 Richter Gedeon Vegyeszet Process for the preparation of risperidone
RU2423692C2 (ru) * 2005-04-27 2011-07-10 ЮЭмЭн ФАРМА ИНК. Вещества для профилактики и лечения панкреатита
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
WO2007093870A2 (en) * 2006-02-15 2007-08-23 Orchid Chemicals & Pharmaceuticals Limited A process for the preparation of risperidone
US7820816B2 (en) * 2006-08-23 2010-10-26 Teva Pharmaceutical Industries Ltd. Process for the synthesis of CMHTP and intermediates thereof
EP2152315B1 (de) 2007-05-25 2016-01-06 Indivior UK Limited Formulierungen von risperidon-verbindungen mit verzögerter freisetzung
MX353752B (es) 2009-01-20 2018-01-26 Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct Los ácidos sórbico y benzoico y sus derivados aumentan la actividad de un neurofármaco.
CN102786521B (zh) * 2011-05-18 2016-01-13 中国医学科学院药物研究所 利培酮晶iii型物质及制备方法与在药品和保健品中应用
CN105367570B (zh) * 2015-12-08 2017-10-10 天津市亨必达化学合成物有限公司 一种利培酮晶i型物质的制备方法
WO2017215593A1 (en) 2016-06-13 2017-12-21 Syneurx International (Taiwan) Corp. Co-crystals of sodium benzoate and uses thereof
CA3027300C (en) 2016-06-13 2023-08-08 Syneurx International (Taiwan) Corp. Co-crystals of lithium benzoate and uses thereof
WO2024146576A1 (zh) * 2023-01-04 2024-07-11 新领医药技术(深圳)有限公司 利培酮透皮施用系统及其制备方法和用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5158952A (en) * 1988-11-07 1992-10-27 Janssen Pharmaceutica N.V. 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
ES2050069B1 (es) 1992-07-10 1994-12-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-il)piperidino)etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido(1,2-a) pirimidin-4-ona.
ES2074966B1 (es) 1994-02-11 1996-06-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il)piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a)pirimidin-4-ona.
EP0877613A2 (de) * 1996-01-26 1998-11-18 PHARMACIA & UPJOHN COMPANY Verwendung einer kombination von delavirdine und einem oder mehreren proteasehemmern bei hiv-1-infizierten patienten
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
IT1294931B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
ATE264329T1 (de) 2000-05-05 2004-04-15 Rpg Life Sciences Ltd Verfahren zur herstellung von antipsychotischem 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-
WO2002012200A1 (en) * 2000-08-08 2002-02-14 Teva Pharmaceutical Industries Ltd. Preparation of risperidone
US20020193386A1 (en) 2002-03-28 2002-12-19 Inigo Pfeiffer Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof

Also Published As

Publication number Publication date
EP1317434A4 (de) 2005-06-22
KR100818875B1 (ko) 2008-04-01
DE60134899D1 (de) 2008-08-28
JP2006028192A (ja) 2006-02-02
US6750341B2 (en) 2004-06-15
EP1317434A1 (de) 2003-06-11
IL154417A (en) 2008-11-03
CA2419314A1 (en) 2002-02-21
US20040229905A1 (en) 2004-11-18
NZ524554A (en) 2005-07-29
WO2002014286A1 (en) 2002-02-21
IS6713A (is) 2003-02-11
PT1783118E (pt) 2008-08-19
EP1982980A1 (de) 2008-10-22
SK2982003A3 (en) 2004-10-05
JP2008056699A (ja) 2008-03-13
US7256195B2 (en) 2007-08-14
AU2001284880A1 (en) 2002-02-25
ES2310410T3 (es) 2009-01-01
CZ2003668A3 (en) 2004-04-14
HRP20030154A2 (en) 2005-04-30
CA2419314C (en) 2006-07-11
JP2004506622A (ja) 2004-03-04
KR20030022389A (ko) 2003-03-15
MXPA03001337A (es) 2005-06-30
KR20080028513A (ko) 2008-03-31
HRP20030154B1 (en) 2009-03-31
JP3751942B2 (ja) 2006-03-08
US20020115673A1 (en) 2002-08-22
WO2002014286A9 (en) 2003-03-27
PL365608A1 (en) 2005-01-10
HUP0302874A2 (hu) 2003-12-29
IL154417A0 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
DE60134899D1 (de) Herstellung von Risperidon
ATE334662T1 (de) Herstellungsverfahren von arzneizubereitungen
NO20030845D0 (no) Utvalgte fusjonerte pyrrolokarbazoler
EE05287B1 (et) Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
SE0102616D0 (sv) Novel compounds
CY1111693T1 (el) Αντιιικοι παραγοντες
EE200100485A (et) Uudsed ühendid ja kompositsioonid proteaasi inhibiitoritena
YU12103A (sh) Polimorfni oblici epotilonskog analoga
NO20032758L (no) Krystallinske former av Atorvastatin
MEP9309A (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same
DE50205571D1 (de) Verfahren zur Herstellung von direkt tablettierbaren Beta-Mannit
YU94103A (sh) Novi derivati sulfonske kiseline
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
ATE546425T1 (de) Herstellung von (r)-2-alkyl-3-phenylpropionsäuren
EP1168918A4 (de) Impfstoff- und gentherapiezusammensetzungen und verfahren zu ihrer herstellung und verwendung
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
DE50115655D1 (de) Verfahren zur herstellung von unsymmetrischen 4,6-bis(aryloxy)pyrimidin-derivaten
ES2055503T3 (es) Diimida de silicio y procedimiento para su fabricacion, y para la fabricacion de nitruro de silicio generado a partir de la misma.
DK1525188T3 (da) Hidtil ukendte derivater af 4,4-dithiobis-(3-aminobutan-1-sulfonater) og sammensætninger, der indeholder dem
WO2001081298A3 (en) Cyclic carboxylic acids as integrin antagonists
CY1111290T1 (el) Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης
MEP56208A (en) Caloporoside derivatives, methods for the production thereof and their use
HUP0401895A2 (hu) Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
SE9800835D0 (sv) New Compounds
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties